Evidence map›Paper›PMID 27595446›Full record

ArticleVaccine2016

Rotavirus vaccine effectiveness in Hong Kong children.

Karene Hoi Ting Yeung, Jacqueline E Tate, Ching Ching Chan, Martin C W Chan, Paul K S Chan, Kin Hung Poon, Sylvia Luen Yee Siu, Genevieve Po Gee Fung, Kwok Leung Ng, Iris Mei Ching Chan and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Vaccine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Genetic diversity of G9, G3, G8 and G1 rotavirus group A strains circulating among children with acute gastroenteritis in Vietnam from 2016 to 2021.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

Karene Hoi Ting YeungDepartment of Paediatrics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region.
Jacqueline E TateEpidemiology Branch, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, USA.
Ching Ching ChanDepartment of Paediatrics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region.
Martin C W ChanDepartment of Microbiology, The Chinese University of Hong Kong, Hong Kong Special Administrative Region.
Paul K S ChanDepartment of Microbiology, The Chinese University of Hong Kong, Hong Kong Special Administrative Region.
Kin Hung PoonDepartment of Paediatrics and Adolescent Medicine, Tuen Mun Hospital, Hong Kong Special Administrative Region.
Sylvia Luen Yee SiuDepartment of Paediatrics and Adolescent Medicine, Tuen Mun Hospital, Hong Kong Special Administrative Region.
Genevieve Po Gee FungDepartment of Paediatrics and Adolescent Medicine, United Christian Hospital, Hong Kong Special Administrative Region.
Kwok Leung NgDepartment of Paediatrics and Adolescent Medicine, United Christian Hospital, Hong Kong Special Administrative Region.
Iris Mei Ching ChanDepartment of Paediatrics, Kwong Wah Hospital, Hong Kong Special Administrative Region.
Pui Tak YuDepartment of Paediatrics, Kwong Wah Hospital, Hong Kong Special Administrative Region.
Chi Hang NgDepartment of Paediatrics, Queen Elizabeth Hospital, Hong Kong Special Administrative Region.
Yu Lung LauDepartment of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong Special Administrative Region.
E Anthony S NelsonDepartment of Paediatrics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region. Electronic address: tony-nelson@cuhk.edu.hk.
Chinese University of Hong Kong · CNKwong Wah Hospital · CNTuen Mun Hospital · CNUnited Christian Hospital · CNNational Center for Immunization and Respiratory Diseases · USQueen Elizabeth Hospital · CNUniversity of Hong Kong · HK

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

backgroundRotavirus is a common infectious cause of childhood hospitalisation in Hong Kong. Rotavirus vaccines have been used in the private sector since licensure in 2006 but have not been incorporated in the government's universal Childhood Immunisation Programme. This study aimed to evaluate rotavirus vaccine effectiveness against hospitalisation.

methodsThis case-control study was conducted in the 2014/2015 rotavirus season in six public hospitals. Hospitalised acute gastroenteritis patients meeting inclusion criteria were recruited and copies of their immunisation records were collected. Case-patients were defined as enrolled subjects with stool specimens obtained in the first 48h of hospitalisation that tested positive for rotavirus, whereas control-patients were those with stool specimens obtained in the first 48h of hospitalisation testing negative for rotavirus. Vaccine effectiveness for administration of at least one dose of either Rotarix(®) (GlaxoSmithKline Biologicals) or RotaTeq(®) (Merck Research Laboratories) was calculated as 1 minus the odds ratio for rotavirus vaccination history for case-patients versus control-patients.

resultsAmong the 525 eligible subjects recruited, immunisation records were seen in 404 (77%) subjects. 31% (162/525 and 126/404) tested positive for rotavirus. In the 404 subjects assessed for vaccine effectiveness, 2.4% and 24% received at least 1 dose of either rotavirus vaccine in case- and control-patients respectively. The unmatched vaccine effectiveness against hospitalisation for administration of at least one dose of either rotavirus vaccines was 92% (95% confidence interval [CI]: 75%, 98%). The matched analyses by age only and both age and admission date showed 96% (95% CI: 72%, 100%) and 89% (95% CI: 51%, 97%) protection against rotavirus hospitalisation respectively.

conclusionsRotavirus vaccine is highly effective in preventing hospitalisation from rotavirus disease in young Hong Kong children.

Indexed as

HospitalizationCase-Control StudiesChild, PreschoolFemaleGastroenteritisHong KongHumansInfantMaleRotavirus InfectionsRotavirus VaccinesVaccines, AttenuatedRIX4414 vaccineRotaTeqRotavirus VaccinesVaccines, AttenuatedGastroenteritisRotavirusRotavirus vaccineVaccine effectiveness

Identifiers

PMID27595446
PMCPMC11974497
OpenAlexW2516985225

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.